Facebook Linkedin RSS Twitter Youtube
Home 2020

GW Pharmaceuticals

Medical Cannabis Pioneers Stake Their Claims
Topics

Medical Cannabis Pioneers Stake Their Claims

FDA Approves GW’s Epidiolex as First Plant-Derived Cannabinoid Prescription Drug
Industry News

FDA Approves GW’s Epidiolex as First Plant-Derived Cannabinoid Prescription Drug

Marijuana Constituent Significantly Reduces Severe Epileptic Seizures
News

Marijuana Constituent Significantly Reduces Severe Epileptic Seizures

Nuvilex Lights Up New Medical Marijuana Company
Drug Discovery

Nuvilex Lights Up New Medical Marijuana Company

Novartis Pays GW Pharm $5M Up Front for Sativex Rights in Multiple Territories
Drug Discovery

Novartis Pays GW Pharm $5M Up Front for Sativex Rights in Multiple Territories

Canada Grants GW Pharm’s Sativex Full Approval for MS Spasticity
Drug Discovery

Canada Grants GW Pharm’s Sativex Full Approval for MS Spasticity

Otsuka Earmarks $12M for Continued Cannabinoid Research Partnership with GW Pharmaceuticals
Cancer

Otsuka Earmarks $12M for Continued Cannabinoid Research Partnership with GW Pharmaceuticals

Cannabis-Based Drug Launched in the U.K. for MS Spasticity
Drug Discovery

Cannabis-Based Drug Launched in the U.K. for MS Spasticity

GW Pharmaceuticals’ Plant for MS and Cancer Pain Drug Gets U.K. GMP Clearance
Bioprocessing

GW Pharmaceuticals’ Plant for MS and Cancer Pain Drug Gets U.K. GMP Clearance

GW Pharm Forges Cannabinoid Alliance with U.K. Metabolic Research Lab
Drug Discovery

GW Pharm Forges Cannabinoid Alliance with U.K. Metabolic Research Lab

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.